Skip to main content
CanSino Biologics Inc. (SHA:688185)
China flag China · Delayed Price · Currency is CNY
54.58
-0.26 (-0.47%)
Apr 25, 2025, 3:00 PM CST

CanSino Biologics Revenue

In the year 2024, CanSino Biologics had annual revenue of 846.34M CNY with 137.01% growth. CanSino Biologics had revenue of 279.26M in the quarter ending December 31, 2024, with 53.90% growth.

Revenue
846.34M
Revenue Growth
+137.01%
P/S Ratio
11.96
Revenue / Employee
566.49K
Employees
1,494
Market Cap
10.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024846.34M489.25M137.01%
Dec 31, 2023357.08M-677.51M-65.49%
Dec 31, 20221.03B-3.27B-75.94%
Dec 31, 20214.30B4.27B17,174.82%
Dec 31, 202024.89M22.61M990.05%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Jiangsu Hengrui Medicine 27.98B
Shenzhen Mindray Bio-Medical Electronics 37.11B
WuXi AppTec 37.92B
Zhangzhou Pientzehuang Pharmaceutical., 10.77B
Aier Eye Hospital Group 20.62B
Sichuan Biokin Pharmaceutical 5.82B
Shanghai United Imaging Healthcare 10.30B
Yunnan Baiyao Group Co.,Ltd 40.03B
Revenue Rankings

CanSino Biologics News

More News